OICHARTS
8 AMThe 8 AM report →

EW

Edwards Lifesciences Corp · XNYS · 131 sessions on record
$86.32▼ −1.76 · −2.0%from $88.08 the session before · Sep 30, 2026 close · end of day
Open
$87.16
High
$87.49
Low
$85.72
Day's range
$1.82.0% of the previous close
VWAP
$86.43close −0.13% from it
Volume, shares
4.89M1.47× the 20-session average
Traded, $
$423.0M
Trades
52.9K92 shares per trade
Previous close
$88.08−1.76 to the close
Market cap
$49.75Bat the close of Sep 30
Day range34% of the way up
$85.72$87.49
52-week range50% of the way up
$76.49 May 11$96.29 Jul 7

−10% from the high · +13% from the low

Options

No listed options on EW

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
EW close over the last 126 sessions, with S&P 500 rebased to the first close77.1786.8296.47axis spans 25%S&P 500EWApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 25 percent.

Quarterly results

consolidated · latest filed Aug 4, 2026 · SEC filings

Revenue $1.74B, +14% on a year earlier; profit $241.9M, −27% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of EW on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Aug 4$1.74B▲ +14%$241.9M▼ −27%0.42▼ −0.7%S&P 500 −0.2% · −0.5 pp
Mar 2026filed May 6$1.65B▲ +17%$380.7M▲ +6.3%0.66▼ −0.5%S&P 500 −0.3% · −0.2 pp
Dec 2025filed Feb 25$1.57B▲ +13%$91.2M▼ −76%0.16—not reached
Sep 2025filed Nov 5$1.55B▲ +15%$291.1M▼ −91%0.50—not reached
Jun 2025filed Aug 4$1.53B▲ +12%$333.2M▼ −9.0%0.56▼ −0.7%S&P 500 −0.2% · −0.5 pp
Mar 2025filed May 6$1.41B▲ +6.2%$358.0M▲ +1.7%0.61▼ −0.5%S&P 500 −0.3% · −0.2 pp
Dec 2024filed Feb 28$1.39B▲ +9.4%$385.6M▲ +4.2%0.65—not reached
Sep 2024filed Nov 5$1.35B▲ +8.9%$3.07B▲ +700%5.13—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of EW on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025$6.07B▲ +12%$1.07B▼ −74%1.83
FY24to Dec 2024$5.44B▲ +8.6%$4.17B▲ +200%6.97
FY23to Dec 2023$5.01B▲ +12%$1.40B▼ −7.8%2.30
FY22to Dec 2022$4.46B▼ −15%$1.52B▲ +1.3%2.44
FY21to Dec 2021$5.23B▲ +19%$1.50B—2.38

Fundamentals

consolidated · filings to Jun 2026 · close $86.32 on Sep 30

EW trades at 50 times trailing earnings, 4.7 times book value, revenue +15% over twelve months, market cap $49.75B.

Valuation
Market cap
$49.75Bon Sep 30
Price to earnings
50consolidated · four quarters to Jun 2026
Trailing EPS
$1.74diluted · consolidated · four quarters to Jun 2026
Price to book
4.7consolidated · balance sheet to Jun 2026
Book value a share
$18.42consolidated · balance sheet to Jun 2026
Debt to equity
—
Return on equity
9.5%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
7.6market cap over revenue, four quarters to Jun 2026
Shares outstanding
576Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$6.51Bfour quarters to Jun 2026
Revenue growth, 12 months
▲ +15%against the twelve months before
Revenue 3-year CAGR
▲ +8.0%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$1.00Bfour quarters to Jun 2026
Profit growth, 12 months
▼ −76%against the twelve months before
Profit 3-year CAGR
—

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 180% of shares, BlackRock, Inc. the largest at 20%, VANGUARD CAPITAL MANAGEMENT LLC 13% and VANGUARD PORTFOLIO MANAGEMENT LLC 9.2%, as filed for the quarter to Jun 2026.

Held by 13F managers
180%of shares outstanding
Shares held
1.03B+0.65% on Mar 2026 among managers filing both
Managers holding
1,2531,198 a quarter earlier
Largest holder
20%BlackRock, Inc.
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of EW
ManagerSharesOf outstandingValueChange on quarter
BlackRock, Inc.118M20%$10.64B+12.4M
VANGUARD CAPITAL MANAGEMENT LLC75.2M13%$6.81B—
VANGUARD PORTFOLIO MANAGEMENT LLC52.8M9.2%$4.78B—
STATE STREET CORP52.6M9.1%$4.76B+51.1K
JPMORGAN CHASE & CO45.6M7.9%$4.15B—
WELLINGTON MANAGEMENT GROUP LLP33.7M5.8%$3.04B−10.4M
GEODE CAPITAL MANAGEMENT, LLC30.9M5.4%$2.78B+4.61M
Bank of New York Mellon Corp28.2M4.9%$2.55B−5.31M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main26M4.5%$2.35B+382K
Ninety One UK Ltd24.7M4.3%$2.23B−117K
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

EW insider trades
InsiderTradeSharesPriceHeld after
Lippis Daniel J.Officersold · Jun 30, 2026619$91.4040,411
Lippis Daniel J.Officerexercised · Jun 30, 2026619$72.6841,030
Zovighian Bernard JDirector,Officersold · Jun 17, 2026523$87.9211,517
Dahl Andrew M.Officersold · May 29, 2026568$86.0815,334
BOBO DONALD E JROfficersold · May 27, 202623,145$86.4298,611
Chopra DaveenOfficersold · May 22, 20261,500$84.6044,324
BOBO DONALD E JROfficersold · May 15, 20268,000$81.8230,970
BOBO DONALD E JROfficersold · May 15, 20269,968$82.0722,798
Lippis Daniel J.Officerexercised · May 18, 2026620$72.6841,031
Lippis Daniel J.Officersold · May 18, 2026620$81.1440,411

Corporate actions

exchange records

No corporate action on record for EW yet.

Price history

131 sessions on record · to Sep 30 · end of day

EW is −4.9% over 20 sessions against the S&P 500's +0.1%, 10% below its 52-week high, realised volatility 27% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $EW %S&P 500 %Difference pp
120 sessionssince Apr 9$79.15▲ +9.1%▲ +12%−3.1
60 sessionssince Jul 7$94.82▼ −9.0%▲ +2.0%−11
20 sessionssince Sep 1$90.74▼ −4.9%▲ +0.11%−5.0
5 sessionssince Sep 23$86.82▼ −0.58%▼ −0.67%+0.09
1 sessionsince Sep 29$88.08▼ −2.0%▼ −0.21%−1.8
Averages of the closeclose against each average
5-session average
$86.65close −0.38% from it
20-session average
$87.44close −1.3% from it
50-session average
$88.44close −2.4% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$2.22.5% of the close
Average day's range, 20
$2.02.3% of the close
Volume against 20 sessions
1.47×4.89M vs 3.44M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
27%≈ ±1.7% a session · moved more than that on 5 of 20
Realised volatility, 60
24%≈ ±1.5% a session · moved more than that on 14 of 60
Beta to S&P 500, 60
0.05moved with S&P 500 on 28 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
12 up · 8 downof 20
Last 60 sessions
30 up · 30 downof 60
Best session, 250
▲ +5.6%Apr 24
Worst session, 250
▼ −3.5%Sep 8

Edwards Lifesciences Corp is held by

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 56% of reported volume on Sep 30, 2026, against 45% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
EW daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 2026880K1.57M56.2%
Sep 29, 2026756K1.2M62.8%
Sep 28, 2026480K1.16M41.3%
Sep 25, 2026550K1.46M37.6%
Sep 24, 2026548K1.24M44.1%
Sep 23, 2026663K1.48M44.7%
Sep 22, 2026413K1.33M30.9%
Sep 21, 2026484K1.28M37.8%
Sep 18, 2026613K1.2M50.9%
Sep 17, 2026752K1.35M55.9%

Filings

SEC EDGAR · newest first
EW SEC filings
FiledFormReport date
Sep 14, 20264Sep 11, 2026
Sep 14, 20264Sep 13, 2026
Sep 11, 20264Sep 11, 2026
Sep 11, 20264Sep 11, 2026
Aug 31, 2026144—
Aug 31, 20264Aug 31, 2026
Aug 28, 2026144—
Aug 28, 20264Aug 28, 2026
Aug 28, 20268-KAug 25, 2026
Aug 26, 2026144—
Aug 26, 2026144—
Aug 26, 20264Aug 26, 2026
Aug 26, 20264Aug 26, 2026
Aug 11, 2026144—
Aug 11, 20264Aug 11, 2026
Aug 4, 2026S-8—
Aug 4, 202610-QJun 30, 2026
Jul 30, 2026144—
Jul 30, 2026144—
Jul 30, 20264Jul 30, 2026
Jul 28, 2026144—
Jul 28, 20264Jul 28, 2026
Jul 27, 2026144—
Jul 27, 20264Jul 27, 2026
Jul 23, 20268-KJul 23, 2026

About Edwards Lifesciences Corp

SEC and exchange records
Company
Edwards Lifesciences Corp
Exchange
XNYS
SEC CIK
1099800
Sessions on record
131
Price source
End of day · delayed
Computed
2 Oct, 02:28 am IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.